NO20002434L - Oksazolidinonderivater og farmasøytiske preparater - Google Patents

Oksazolidinonderivater og farmasøytiske preparater

Info

Publication number
NO20002434L
NO20002434L NO20002434A NO20002434A NO20002434L NO 20002434 L NO20002434 L NO 20002434L NO 20002434 A NO20002434 A NO 20002434A NO 20002434 A NO20002434 A NO 20002434A NO 20002434 L NO20002434 L NO 20002434L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
oxazolidinone derivatives
organisms
compound
formula
Prior art date
Application number
NO20002434A
Other languages
English (en)
Other versions
NO317291B1 (no
NO20002434D0 (no
Inventor
Jr Jackson B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20002434L publication Critical patent/NO20002434L/no
Publication of NO20002434D0 publication Critical patent/NO20002434D0/no
Publication of NO317291B1 publication Critical patent/NO317291B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002434A 1997-11-12 2000-05-11 Oksazolidinonderivater og farmasoytiske preparater NO317291B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO20002434L true NO20002434L (no) 2000-05-11
NO20002434D0 NO20002434D0 (no) 2000-05-11
NO317291B1 NO317291B1 (no) 2004-10-04

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002434A NO317291B1 (no) 1997-11-12 2000-05-11 Oksazolidinonderivater og farmasoytiske preparater

Country Status (21)

Country Link
US (1) US5998406A (no)
EP (1) EP1030852B1 (no)
JP (1) JP2001522849A (no)
KR (1) KR20010031953A (no)
CN (1) CN1154644C (no)
AT (1) ATE250054T1 (no)
AU (1) AU739055B2 (no)
BR (1) BR9813985A (no)
CA (1) CA2303959A1 (no)
DE (1) DE69818294T2 (no)
DK (1) DK1030852T3 (no)
ES (1) ES2207010T3 (no)
HU (1) HUP0100470A3 (no)
IL (1) IL136062A (no)
NO (1) NO317291B1 (no)
NZ (1) NZ504503A (no)
PT (1) PT1030852E (no)
RU (1) RU2215740C2 (no)
SK (1) SK284577B6 (no)
TR (1) TR200001330T2 (no)
WO (1) WO1999024428A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010052615A (ko) 1998-06-05 2001-06-25 다비드 에 질레스 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
WO2004014897A1 (en) * 2002-08-12 2004-02-19 Pharmacia & Upjohn Company Llc N-aryl-2-oxazolidinones and their derivatives
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0413838A (pt) * 2003-08-25 2006-10-24 Warner Lambert Co compostos de ariloxazolidinona antimicrobianos
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
JP2008521792A (ja) * 2004-11-29 2008-06-26 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌薬としてのジアゼピンオキサゾリジノン
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
EP1899331B1 (en) 2005-06-29 2009-11-25 Pharmacia & Upjohn Company LLC Homomorpholine oxazolidinones as antibacterial agents
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
EP2181994B1 (en) 2006-03-31 2014-05-28 Research Foundation Itsuu Laboratory Antimicrobial compounds
US8530646B2 (en) 2007-10-02 2013-09-10 Research Foundation Itsuu Laboratory Oxazolidinone derivative having 7-membered hetero ring
KR20130102614A (ko) 2010-11-03 2013-09-17 욱크하르트 리미티드 인산 모노-(1-[4-[(s)-5-(아세틸아미노메틸)-2-옥소-옥사졸리딘-3-일]-2,6-디플루오로페닐]-4-메톡시메틸피페리딘-4-일) 에스테르의 제조 방법
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ES2059467T3 (es) * 1987-10-21 1994-11-16 Du Pont Merck Pharma Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ATE112773T1 (de) * 1988-09-15 1994-10-15 Upjohn Co 5-indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(nitrogen- substituierte)phenyl-5-beta-amidomethyloxazolid n-2-one.
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
JP3698724B2 (ja) * 1993-11-22 2005-09-21 ファルマシア・アンド・アップジョン・カンパニー 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
DK1030852T3 (da) 2003-12-22
TR200001330T2 (tr) 2000-11-21
US5998406A (en) 1999-12-07
NO317291B1 (no) 2004-10-04
EP1030852B1 (en) 2003-09-17
PT1030852E (pt) 2004-02-27
CN1154644C (zh) 2004-06-23
WO1999024428A1 (en) 1999-05-20
ES2207010T3 (es) 2004-05-16
ATE250054T1 (de) 2003-10-15
IL136062A (en) 2004-02-08
JP2001522849A (ja) 2001-11-20
HUP0100470A3 (en) 2002-08-28
HUP0100470A2 (hu) 2002-05-29
KR20010031953A (ko) 2001-04-16
RU2215740C2 (ru) 2003-11-10
EP1030852A1 (en) 2000-08-30
HK1030373A1 (en) 2001-05-04
NZ504503A (en) 2002-10-25
BR9813985A (pt) 2000-09-26
DE69818294D1 (de) 2003-10-23
IL136062A0 (en) 2001-05-20
AU739055B2 (en) 2001-10-04
DE69818294T2 (de) 2004-07-08
SK284577B6 (sk) 2005-07-01
CN1271358A (zh) 2000-10-25
SK6182000A3 (en) 2000-12-11
AU1277899A (en) 1999-05-31
CA2303959A1 (en) 1999-05-20
NO20002434D0 (no) 2000-05-11

Similar Documents

Publication Publication Date Title
NO20002434D0 (no) Oksazolidinonderivater og farmasøytiske preparater
DE69714418D1 (de) Azolylpiperazinylphenyloxazolidinone als antimikrobielle mittel
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
NO950297D0 (no) Prolinamidderivater
SE9604786D0 (sv) New compounds
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
ATE239376T1 (de) Antimikrobielle zusammensetzung.
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
WO2001003685A3 (en) Novel prodrugs for antimicrobial amidines
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
DE69613975D1 (de) Dialkyltiacumicine
DE60005517D1 (de) Kaliumkanal-blockierende mittel
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
MY122570A (en) Benzamide derivatives and drugs containing the same
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
ATE163294T1 (de) Die antibiotika ge 37468 a, b und c
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
PT740657E (pt) 4-aril-isoindois com actividade analgesica
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas